Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

Not Applicable

Completed

• Conditions: Osteoporosis; Hip Fracture

• Registration Number: NCT00175175
• Lead Sponsor: University of Alberta

Brief Summary

Patients with hip fractures have suffered the most devastating consequence of osteoporosis; and yet, they are rarely if ever tested or treated for the condition, even though they remain at high risk of recurrent fracture.

We hypothesize that, compared with usual care, an allied health professional-run osteoporosis service (case management) will be able to increase testing and treatment of osteoporosis in patients at high risk of fracture.

Detailed Description

Patients with hip fractures have suffered the most devastating consequence of osteoporosis; and yet, they are rarely if ever tested or treated for the condition, even though they remain at high risk of recurrent fracture.

We hypothesize that, compared with usual care, an allied health professional-run osteoporosis service (case management) will be able to increase testing and treatment of osteoporosis in patients at high risk of fracture.

Study Timeline

• Study Start: 2002-03
• Study First Submitted: 2005-09-09
• Study First Submitted QC: 2005-09-09
• Study First Posted: 2005-09-15
• Status Verified: 2006-09
• Last Update Submitted: 2006-09-13
• Last Update Posted: 2006-09-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 220

Inclusion Criteria

• hip fracture patient > 50 years of age
• able to give consent (or proxy consent available)
• lives within health region
• no contraindications to bisphosphonate therapy

Exclusion Criteria

• refuses to participate or consent
• dementia or delirium without a proxy consent available
• nursing home or longterm care
• pathologic fracture
• chronic glucocorticoid use
• already receiving prescription osteoporosis treatment (calcium and vitamin D do not preclude inclusion)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
The proportion of patients taking bisphosphonate therapy within 6 months of hip fracture

Secondary Outcome Measures

Name	Time	Method
Proportion of patients taking prescription osteoporosis treatment at 6 months and 12 months
Proportion in receipt of a BMD test at 6 months and 12 months
Proportion still adherent to osteoporosis treatments at 6 months and 12 months
Proportion of patients with recurrent fractures at 6 months and 12 months
Cost effectiveness analyses

Trial Locations

Locations (1)

University of Alberta Hospitals; 🇨🇦 Edmonton, Alberta, Canada